Genmab (GMAB) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

GMAB Genmab

Watchlist

20.170
-0.480-2.32%

Close Dec 13 16:00 ET

20.170
0.0000.00%

Post 20:01 ET

12.81BMarket Cap19.85P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

TD Cowen Maintains Genmab(GMAB.US) With Hold Rating
Moomoo NewsDec 13 07:31 ET · Ratings
TD Cowen Reaffirms Their Hold Rating on Genmab (GMAB)
TipRanksDec 13 07:26 ET · Ratings
RBC Capital Keeps Their Buy Rating on Genmab A/S (0MGB)
TipRanksDec 12 20:51 ET · Ratings
Top Gap Ups and Downs on Thursday: CIEN, WBD, ADBE and More
Moomoo NewsDec 12 18:00 ET · Markets
Genmab to Hold 2024 R&D Update and ASH Data Review Meeting
GlobeNewswireDec 11 08:20 ET
City of Hope Reports Novel Immunotherapy in Clinical Trial Shows Promise for Patients With Relapsed or Difficult to Treat Chronic Lymphocytic Leukemia (CLL)
BusinesswireDec 10 08:00 ET

Comments

Stock_Drift

Sep 15 09:58

$Genmab (GMAB.US)$

亿顺利发春2888

Jul 12 08:38

$Genmab (GMAB.US)$ growth up positive trend

亿顺利发春2888

Jul 11 08:53

$Genmab (GMAB.US)$ positive growth $26, growth upwards trend

亿顺利发春2888

Jul 10 15:28

$Genmab (GMAB.US)$ growth is very slow

Meltyy

Jun 28 02:47

$Genmab (GMAB.US)$ $AbbVie (ABBV.US)$
EPKINLY (Epcoritamab) Now Approved for Patients w/ Follicular Lymphoma (FL)
» Positive results in Ph1/2 EPCORE® NHL-1 study for R/R FL
» Offers off-the-shelf T-cell therapy
» First-of-its-kind antibody for both R/R FL & DLBCL after prior treatments (2+ lines)

Heat List

Overall

No Data